iPSCs and Exosomes: Partners in Crime Fighting Cardiovascular Diseases

Giulia Germena1,2, Rabea Hinkel1,2,3

  • 1Laboratory Animal Science Unit, Leibniz-Institut für Primatenforschung, Deutsches Primatenzentrum GmbH, Kellnerweg 4, 37077 Göttingen, Germany.

Insights

Induced pluripotent stem cells (iPSCs) offer a promising avenue for cardiovascular regeneration and disease modeling. This review explores iPSC applications in understanding heart disease mechanisms and developing novel regenerative therapies.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Science
  • Stem Cell Biology

Background:

  • Cardiovascular diseases (CVDs) represent a major global health challenge, necessitating innovative treatment strategies.
  • Cardiac tissue engineering and induced pluripotent stem cell (iPSC) technology are emerging as powerful tools for CVD treatment.
  • Regenerative medicine approaches, including artificial tissue and organoid generation, are advancing for cardiovascular repair.

Purpose of the Study:

  • To review current approaches in heart regeneration, with a specific emphasis on the application of iPSCs.
  • To highlight the utility of iPSCs in elucidating molecular mechanisms of cardiovascular pathologies.
  • To explore the potential of iPSCs in drug discovery and regenerative therapies for cardiovascular diseases.

Main Methods:

  • Review of existing literature on cardiac tissue engineering and iPSC-based cardiovascular regeneration.
  • Analysis of iPSC applications in disease modeling and drug screening for cardiovascular conditions.
  • Exploration of emerging concepts such as stem cell-secreted biomolecules (e.g., exosomes) and immunomodulation in heart regeneration.

Main Results:

  • iPSCs provide a robust platform for studying the molecular underpinnings of cardiovascular diseases.
  • iPSC-derived models show significant potential for accelerating cardiovascular drug discovery.
  • Novel insights into the role of exosomes and immune system modulation in enhancing cardiac regeneration are emerging.

Conclusions:

  • iPSC technology is pivotal for advancing cardiovascular regeneration and understanding disease pathogenesis.
  • The integration of iPSCs with tissue engineering holds significant promise for future cardiovascular disease treatments.
  • Further research into stem cell-derived factors and immunomodulatory strategies could revolutionize heart regeneration.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.9K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
133
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K